Search results
Emergent to sell US sterile manufacturing facility to Bora
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe addition will also support Bora Biologics, the company's division focused on development and...
Weight loss drug contender Zealand Pharma jumps 23% on trial results
CNBC· 5 hours agoPetrelintide was "judged to be safe and well tolerated at all dose levels" and the results provided...
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 day agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease
Pharmaceutical Technology via Yahoo Finance· 4 hours agoIn March 2024, the FDA oncologic drugs advisory committee recommended Johnson & Johnson’s Carvykti...
Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet...
Clinical Trials Arena via Yahoo Finance· 2 hours agoLeading data and analytics company GlobalData expects that the US will contribute the most to the...
Eli Lilly Has a New Drug That Could Push the Stock Higher | The Motley Fool
The Motley Fool· 21 hours agoThe stock of Eli Lilly (LLY -0.61%), the world's largest pharmaceutical company, keeps reaching new all-time highs, largely off the back of its weight loss ...
Emergent BioSolutions sells Baltimore facility to Bora Pharmaceuticals By Investing.com
Investing.com· 1 day agoEmergent BioSolutions Inc. (NYSE: EBS), a biopharmaceutical company, has struck a deal to divest its...
WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe
Pharmaceutical Technology via Yahoo Finance· 1 hour agoThe company increased the list price of the drug earlier this year, with a four-week supply now...
Why has the Sarepta stock price (SRPT) gone up more than 35%? | Invezz Why has the Sarepta stock...
Invezz· 6 hours agoSarepta Therapeutics (NASDAQ: SRPT), a pharmaceutical company that describes itself as specializing in “precision genetic medicine for rare diseases”, saw ...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 3 hours agoThe decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable...